Clinical predictors of prolonged clinical benefit (PCB) from pemetrexed (P) therapy in metastatic non-small cell lung cancer (mNSCLC).
N. Hashemi Sadraei
No relevant relationships to disclose
C. Jones
No relevant relationships to disclose
A. Tan
No relevant relationships to disclose
P. Elson
No relevant relationships to disclose
T. Mekhail
Consultant or Advisory Role - Genentech
Honoraria - Genentech; Lilly
Research Funding - Lilly
N. A. Pennell
Consultant or Advisory Role - Boehringer Ingelheim
Research Funding - Genentech